SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (931)8/29/1998 7:37:00 PM
From: Bradpalm1  Read Replies (2) of 1016
 
BigKNY3,

Wole initially gained some degree of credibility when Vivus was rocketing up to the low 80s long ago but his track record since has been deplorable. His most recent strong buy recommendation seems more like an act of desperation rather than an honest look at the overall situation.

Unfortunately Vivus will continue to fall under the weight of extreme mismanagement, margin calls and the continued correction of the market. Muse will always have a niche role in the treatment of ED but it will never live up to its initial promise.

Bradpalm1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext